The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Rheinland-Pfalz; Rheinhessen-Pfalz; Mainz, Kreisfreie Stadt
Location of affected unit(s)
Mainz
Sector
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
2,000 jobs Number of planned job creations
Announcement Date
10 September 2022
Employment effect (start)
10 September 2022
Foreseen end date
10 September 2024
Description
As announced on 8 September 2022, the German pharmaceutical company BioNTech will be expanding its workforce by approximately 2,000 within the next years. BioNTech intends to increase its workforce at its headquarters in Mainz from 3,000 to 5,000 employees. The company is currently expanding its research and production facilities in Mainz and intends to invest several billion euros within in the next years.
Additionally, BioNTech intends to create new Jobs in Marburg. However, there are currently no information on number of jobs nor a timeframe available.
Sources
10 September 2022: Die Welt (online) (www.welt.de)
Eurofound (2022), BioNTech, Business expansion in Germany, factsheet number 107301, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/107301.